Aardvark Therapeutics, Inc. 10-Q filing
Filed 2026-05-07 · Report date 2026-03-31 · 2026
Filing metadata
- Accession number
- 0001193125-26-210675
- Form type
- 10-Q
- CIK
- 0001774857
- Primary document
- https://www.sec.gov/Archives/edgar/data/1774857/000119312526210675/ck0001774857-20260331.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Aardvark Therapeutics, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-22.5M | - | - |
| Net Income | $-21.6M | - | - |
| Eps Basic | -0.99 | - | - |
| Eps Diluted | -0.99 | - | - |
| Cash And Equivalents | $62.4M | - | - |
| Total Assets | $98.6M | - | - |
| Total Liabilities | $11.6M | - | - |
| Shareholders Equity | $87.0M | - | - |
| Operating Cash Flow | $-18.9M | - | - |